Targeting Toll-like receptors by chloroquine protects mice from experimental cerebral malaria

Keyphrases

• Toll-like 100%
• Chloroquine 100%
• Experimental Cerebral Malaria 100%
• Cerebral Malaria 60%
• Dendritic Cells 60%
• Toll-like Receptor 9 (TLR9) 60%
• Plasmodium Berghei ANKA 40%
• Malaria 20%
• C57BL 20%
• Nitric Oxide 20%
• Innate Immune Response 20%
• Adaptive Immune Response 20%
• Inflammatory Cytokines 20%
• Critical Links 20%
• Inflammatory Response 20%
• Endocytic 20%
• Malaria Pathogenesis 20%
• Receptor Signaling 20%
• Inflammatory Mediators 20%
• Endosomal Acidification 20%
• MHC Class II 20%
• Malaria Model 20%
• Promising Strategies 20%
• CD4+ T Cells 20%
• Th1 Cells 20%
• Immunomodulator 20%

Medicine and Dentistry

• Cerebral Malaria 100%
• Chloroquine 100%
• Toll Like Receptor 100%
• Dendritic Cell 50%
• Toll Like Receptor 9 50%
• Infection 33%
• Single Drug Dose 16%
• Receptor 16%
• C57BL/6 16%
• Mediator 16%
• Cytokine 16%
• Serositis 16%
• Oligodeoxynucleotide 16%
• Tumor Necrosis Factor 16%
• Nitric Oxide 16%
• Adaptive Immunity 16%
• Innate Immunity 16%
• T-Helper Cell 16%
• Immunomodulating Agent 16%
• Antimalarial 16%
• Th1 Cell 16%

Immunology and Microbiology

• Toll-Like Receptor 100%
• Chloroquine 100%
• Dendritic Cell 60%
• TLR9 60%
• Plasmodium berghei 40%
• Myeloid 20%
• Adaptive Immune System 20%
• Innate Immune System 20%
• Tumor Necrosis Factor 20%
• Mediator 20%
• Proinflammatory Cytokine 20%
• Inflammation Response 20%
• C57BL 6 Mouse 20%
• T-Helper Cell 20%
• Th1 Cell 20%
• Immunomodulating Drugs 20%